Reuters logo
BRIEF-Threshold Pharmaceuticals reports Q1 loss per share of $0.07
May 15, 2017 / 8:45 PM / in 6 months

BRIEF-Threshold Pharmaceuticals reports Q1 loss per share of $0.07

May 15 (Reuters) - Threshold Pharmaceuticals Inc

* Threshold Pharmaceuticals reports first quarter financial results

* Definitive merger agreement between Threshold and Molecular Templates expected to close mid-2017

* Qtrly loss per share $0.07

* Initiation of phase 1 clinical trial of Evofosfamide in combination with Ipilumumab on track to start in mid-2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below